JTC Employer Solutions Trustee’s ARK Genomic Revolution ETF ARKG Stock Holding History

JTC Employer Solutions Trustee’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,237	Closed	-$32K	–	322
2024 Q3	$32K	Hold	1,237	–	–	﹤0.01%	261
2024 Q2	$29K	Hold	1,237	–	–	﹤0.01%	267
2024 Q1	$36K	Hold	1,237	–	–	﹤0.01%	268
2023 Q4	$42K	Sell	1,237 -1,916	-61%	-$52.1K	﹤0.01%	263
2023 Q3	$87K	Hold	3,153	–	–	0.01%	205
2023 Q2	$107K	Hold	3,153	–	–	0.01%	185
2023 Q1	$95K	Hold	3,153	–	–	0.01%	200
2022 Q4	$89K	Hold	3,153	–	–	0.01%	211
2022 Q3	$104K	Buy	3,153 +1,916	+155%	+$70.3K	0.02%	160
2022 Q2	$39K	Hold	1,237	–	–	0.01%	207
2022 Q1	$57K	Hold	1,237	–	–	0.01%	197
2021 Q4	$75K	Hold	1,237	–	–	0.01%	186
2021 Q3	$92K	Hold	1,237	–	–	0.01%	174
2021 Q2	$115K	Buy	+1,237	New	+$105K	0.02%	148

Other funds holding ARKG

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

JTC Employer Solutions Trustee's ARKG Position: Q4 2024 in Review

JTC Employer Solutions Trustee sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2024, closing a stake of 1,237 shares — an estimated $32K sold.

JTC Employer Solutions Trustee first reported a position in ARKG in Q2 2021 and held it in 14 quarters. The position peaked at $115K in Q2 2021. 238 funds tracked by Wall St. Rank hold ARKG as of Q4 2024.

JTC Employer Solutions Trustee reported no remaining ARK Genomic Revolution ETF position as of Q4 2024 after selling out during the quarter.
JTC Employer Solutions Trustee sold 1,237 ARK Genomic Revolution ETF shares in Q4 2024, an estimated $32K.
JTC Employer Solutions Trustee first reported a position in ARK Genomic Revolution ETF in Q2 2021 and held it in 14 quarters.
JTC Employer Solutions Trustee's ARK Genomic Revolution ETF position peaked at $115K in Q2 2021.
238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2024.

Based on JTC Employer Solutions Trustee's 13F filing for Q4 2024, filed 13 Jan 2025.